2011 Scrip 100: All roads lead to personalised meds
This article was originally published in Scrip
Executive Summary
Stakeholders ranging from pharmaceutical companies to regulators and payers are feeling their way around the emerging field of personalised medicine. Sooner or later, the industry will realise that it has to move towards this approach, writes Dr Sukaina Virji-Jeganathan.